MGTA-145
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MGTA-145, covering 2022-09-10 to 2025-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease [Phase 2]